CORBF (Global Cord Blood) EPS (Basic): $0.64 (TTM As of Mar. 2022)


CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood EPS (Basic)?

Global Cord Blood CORBF 12 EPS (Basic) is $0.64 as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

Global Cord Blood's basic earnings per share (Basic EPS) for the three months ended in Mar. 2022 was $0.14. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2022 was $0.64.

Global Cord Blood's EPS (Diluted) for the three months ended in Mar. 2022 was $0.14. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $0.64.

Global Cord Blood's EPS without NRI for the three months ended in Mar. 2022 was $0.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2022 was 0.66.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Global Cord Blood  (OTCPK:CORBF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Global Cord Blood EPS (Basic) Related Terms

Global Cord Blood EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood EPS (Basic) Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.36 0.55 0.64 0.65

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.17 0.16 0.17 0.14
CORBF
12GF Score
Global Cord Blood Corp CORBF
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Cord Blood EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Global Cord Blood's Basic EPS for the fiscal year that ended in Mar. 2022 is calculated as

Basic EPS (A: Mar. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(78.975-0)/121.551
=0.65

Global Cord Blood's Basic EPS for the quarter that ended in Mar. 2022 is calculated as

Basic EPS (Q: Mar. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(16.505-0)/121.466
=0.14

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $0.64 mean?
Global Cord Blood (CORBF) has a EPS (Basic) of $0.64 as of Mar. 2022. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Global Cord Blood and its competitors.
Is Global Cord Blood's EPS (Basic) too high?
Global Cord Blood's current EPS (Basic) is $0.64. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's EPS (Basic) compare to PRE and LMDX?
Global Cord Blood's EPS (Basic) of $0.64 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Global Cord Blood and its competitors. Global Cord Blood's current EPS (Basic) is $0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current EPS (Basic) of $0.64. The current EPS (Basic) is $0.64. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current EPS (Basic) is $0.64 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price